Merck Provides Update on KEYNOTE-407 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. INTC
9. CME
10. ADBE

Go back to Merck Provides Update on KEYNOTE-407 Trial
Merck & Co. (NYSE: MRK) Delayed: 120.76 +1.67 (1.40%)
Previous Close $119.09    52 Week High $65.46 
Open $120.04    52 Week Low $47.97 
Day High $122.71    P/E 82.15 
Day Low $119.95    EPS $1.47 
Volume 13,118,922